Our News

Published Scientific Articles

p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes

Switching cyclin D-Cdk4 kinase activity on and off

Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity

Concarlo in the News

Life Sciences Review special edition on BioTech Startup 2022

US biotech start-up set to have huge impact on breast cancer treatment landscape

Concarlo: targeting proliferation and resistance in one go

Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer

Webinars & Talks

Stacy Blain and Arthur Klausner on NewYorkBIOs Virtual Breakfast Series

Heroes of Healthcare –  Episode 50: Shutting the Door on Cancer Cells

Beyond Biotech podcast 24: Concarlo Therapeutics

Targeting p27Kip1 to Treat Drug-Resistance Cancer

Awards

“The reward for work well done is the opportunity to do more”

—Jonas Salk

RESI’s Innovator’s Pitch Challenge Winner

Princeton University Women’s Showcase

The 50 Most admired companies: CIO Bio

Top 100 entreprenuers: Alumni List

Top Biotech Startup 2022
Awarded by: Life Sciences Review